Afficher la notice abrégée

dc.contributor.authorCerón-Hernández, Jorge
dc.contributor.authorMartínez Navajas, Gonzalo 
dc.contributor.authorSánchez-Manas, Jose Manuel
dc.contributor.authorMolina, María Pilar
dc.contributor.authorXie, Jiajun
dc.contributor.authorAznar-Peralta, Inés
dc.contributor.authorGarcía-Díaz, Abel
dc.contributor.authorPerales Romero, Sonia 
dc.contributor.authorTorres Perales, Carolina 
dc.contributor.authorSerrano Fernández, María José 
dc.contributor.authorReal Luna, Pedro José 
dc.date.accessioned2025-04-02T06:43:36Z
dc.date.available2025-04-02T06:43:36Z
dc.date.issued2025-04-01
dc.identifier.citationCeron-Hernandez, J.; Martinez-Navajas, G.; Sanchez-Manas, J.M.; Molina, M.P.; Xie, J.; Aznar-Peralta, I.; Garcia-Diaz, A.; Perales, S.; Torres, C.; Serrano, M.J.; et al. Oncogenic KRASG12D Transfer from Platelet-like Particles Enhances Proliferation and Survival in Non-Small Cell Lung Cancer Cells. Int. J. Mol. Sci. 2025, 26, 3264. https://doi.org/10.3390/ijms26073264es_ES
dc.identifier.urihttps://hdl.handle.net/10481/103376
dc.descriptionThis study was supported by FEDER/Junta de Andalucia-Consejeria de Transformacion Economica, Industria, Conocimiento y Universidades (B-CTS-676-UGR) and the PID2019-110153RB-I00 founded by the Ministry of Economy and Competitiveness to P.J.R.; the Spanish Health Institute Carlos III to M.J.S. (PI21/00786). J.C.-H. was supported by the PhD program from the Ministry of Universities (FPU18/03410) and received a grant from the same institution for international mobility. G.M.-N. was supported by the PFIS fellowship from the Spanish Health Institute Carlos III (FI17/00178) and received an EMBO scientific program grant (9618) for international mobility. J.M.S.-M. was supported by the Grants for the Predoctoral Recruitment of Research Trainees—Predoctoral student (PREDOC_01765). I.A.-P. was supported by the PFIS fellowship from the Spanish Health Institute Carlos III (FI22/00273). A.G.D. was supported by PIP-0192-2020 from the Health Counselling of the Andalusian Government and GlaxoSmithKline (GSK).es_ES
dc.descriptionSupplementary Materials. The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/ijms26073264/s1es_ES
dc.description.sponsorshipFEDER/Junta de Andalucía (B-CTS-676-UGR)es_ES
dc.description.sponsorshipMinistry of Economy and Competitiveness PID2019-110153RB-I00es_ES
dc.description.sponsorshipSpanish Health Institute Carlos III (PI21/00786), (FI17/00178), (FI22/00273)es_ES
dc.description.sponsorshipMinistry of Universities (FPU18/03410)es_ES
dc.description.sponsorshipEMBO scientific program grant (9618)es_ES
dc.description.sponsorshipPredoctoral student (PREDOC_01765)es_ES
dc.description.sponsorshipHealth Counselling of the Andalusian Government PIP-0192-2020es_ES
dc.description.sponsorshipGlaxoSmithKline (GSK)es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectKRASes_ES
dc.subjectplatelet-like-particleses_ES
dc.subjectnon-small cell lung cancer;es_ES
dc.subjectoncogene transferes_ES
dc.titleOncogenic KRASG12D Transfer from Platelet-like Particles Enhances Proliferation and Survival in Non-Small Cell Lung Cancer Cellses_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3390/ijms26073264
dc.type.hasVersionVoRes_ES


Fichier(s) constituant ce document

[PDF]

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepté là où spécifié autrement, la license de ce document est décrite en tant que Attribution-NonCommercial-NoDerivatives 4.0 Internacional